1595 related articles for article (PubMed ID: 9490916)
1. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
2. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
[TBL] [Abstract][Full Text] [Related]
4. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
5. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
[TBL] [Abstract][Full Text] [Related]
6. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?
Jung SM; Sonoda M; Tsuji K; Jimi A; Nomura S; Kanaji T; Moroi M
Platelets; 2010; 21(2):101-11. PubMed ID: 20063990
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster.
Yamamoto H; Vreys I; Stassen JM; Yoshimoto R; Vermylen J; Hoylaerts MF
Thromb Haemost; 1998 Jan; 79(1):202-10. PubMed ID: 9459348
[TBL] [Abstract][Full Text] [Related]
8. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
[TBL] [Abstract][Full Text] [Related]
9. VWF attributes--impact on thrombus formation.
Reininger AJ
Thromb Res; 2008; 122 Suppl 4():S9-13. PubMed ID: 18929523
[TBL] [Abstract][Full Text] [Related]
10. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
11. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
[TBL] [Abstract][Full Text] [Related]
12. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
[TBL] [Abstract][Full Text] [Related]
13. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
Meyer D
Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
15. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
16. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
18. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions.
Zhou Z; Bernardo A; Zhu Q; Guan Y; Sun W; Lopez JA; Jing N; Dong JF
Thromb Haemost; 2009 Sep; 102(3):529-37. PubMed ID: 19718474
[TBL] [Abstract][Full Text] [Related]
19. Platelet adhesion to collagen.
Nuyttens BP; Thijs T; Deckmyn H; Broos K
Thromb Res; 2011 Jan; 127 Suppl 2():S26-9. PubMed ID: 21193111
[TBL] [Abstract][Full Text] [Related]
20. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
